Jonathan
Leaving the APG/HbA1 debate and any associated angst aside for a moment:
I recently did have a query from one of our diabetologists about measuring
fructosamine (glycated albumin, APG rapid) in haemodialysis patients arising
from a paper by Inaba et al. in J Am Soc Nephrol 18: 896-903, 2007 that
suggested it is better than glycated haemoglobin (APG), as an indicator of
glycaemia (APG) in those patients. Have I got all the terminology right?
I established one or two sites that could still measure fructosamine for us
but this hasn't yet been followed up by them sending any samples to my
knowledge. However it is possible fructosamine (glycated... etc.) may make a
limited comeback.
I suppose for APG, they could just measure the glucose by continuous
monitoring. The average Sinclair spectrum (or possibly a Cerner (South
Cluster UK in-joke)) could handle the calculation of the 'average' part of
the APG equation.
Regards
Steve
ps: average = mean, median or mode?(I suspect I shouldn't ask).
________________________________________________________
Dr Stephen Frost, MSc, PhD, FRCPath, MCB, CChem, MRSC
Department of Clinical Biochemistry and Immunology
Brighton and Sussex University Hospitals NHS trust
The Princess Royal Hospital
Lewes Road
Haywards Heath
West Sussex
RH16 4EX
Tel 01444 441881 ext 8197
Fax 01444 459635
email [log in to unmask]
-----Original Message-----
From: Jonathan G. Middle [mailto:[log in to unmask]]
Sent: 12 July 2007 12:18
To: [log in to unmask]
Subject: UK NEQAS for fructosamine
I seem to be getting a few more requests from laboratories interested in
performing fructosamine assays and wanting this analyte included in my Hba1c
scheme.
In the past, there was been very little interest and numbers of potential
participants have been non-viable.
Has the situation changed?
If there are 20 of you out there in the UK (and outside of the UK as well) I
might re-instate this analyte.
Could you email me and not the list please. I'll report back to the list
and to participants,
Cheers
J
Dr Jonathan Middle
Deputy Director, UK NEQAS Birmingham
0121 414 7300, fax 0121 414 1179
-----------------------------------------------
Please use [log in to unmask] for PERSONAL work-related email
Please use [log in to unmask] for UK NEQAS service-related email
For work-unrelated personal email please ask for my private Gmail address
-----------------------------------------------
All opinions expressed in this email are mine alone and are not necessarily
representative of the views of the UK NEQAS organisation, UK NEQAS
Birmingham (Wolfson EQA Laboratory), University Hospital Birmingham NHS
Foundation Trust or University of Birmingham.
------------------------------------------------
The content of this message may be confidential and legally priviledged. If
you receive it in error please delete it immediately from your system.
Thank you.
------------------------------------------------
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
This electronic message contains information from Brighton and Sussex University Hospitals NHS Trust, which may be privileged or confidential. The information is intended to be for the use of the individual(s) or entity named above. If you are not the intended recipient be aware that any disclosure, copying, distribution or use of the contents of this information is prohibited. If you have received this electronic message in error, please notify us immediately at [log in to unmask]
This Trust is committed to openness and transparency, and this commitment is supported by the Freedom of Information Act 2000. Under the Act, any recorded information held by the Trust, including this message, unless legally exempt, may be subject to public disclosure.
Activity and use of the Brighton and Sussex University Hospitals NHS Trust E-mail system is monitored to secure its effective operation and for other lawful business purposes. Communications using this system will also be monitored for viruses and other harmful material.
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|